Rabbit as a biological model for experimental research (literature review)

  • Authors: О.М. Tkachuk, T.V. Tkachuk
  • UDC: 636.92:615
  • DOI: 10.33273/2663-4570-2021-91-2-109-114
Download attachments:

LI Medved’s Research Centre of Preventive Toxicology, Food and Chemical Safety, Ministry of Health, Ukraine (State Enterprise), Kyiv, Ukraine


ABSTRACT. Objective. To analyze and generalize the data of modern literature on the use of rabbits for laboratory experimental studies and substantiate the prospects for their further use.

Materials and Methods. Analytical methods were used in the work: collection of scientific information on the problem, analysis of published data from PubMed libraries and scientific generalization of the results.

Results and Conclusions. Principles have been substantiated regarding the prospects for the further use of rabbits for laboratory experimental studies. Science has advanced long ago, and ethical alternative scientific testing methods have now been developed and implemented to provide more reliable results. But if in some areas of scientific research, rabbits have ceased to be used altogether, then in other areas, on the contrary, the use of rabbits is rapidly increasing every year. Currently, there is no alternative to using rabbits for the production of antibodies, recombinant proteins. Testing in laboratory animals is the best method for detecting consequences such as cancer and birth defects. Genetically modified rabbits - new perspectives opening up in scientific research. With the development of new technologies for genome editing, especially CRISPR/Cas9 and its modifications, it has become possible to obtain with high efficiency an increasing number of transgenic animals with precisely specified genetic modifications for solving a wide variety of problems. The use of animals in experiments is critical for some areas of scientific research, since this complexity of the structure of the organism cannot be duplicated in cell culture or using computer models.

Key Words: rabbits, maintenance, testing on animals, human health.



1. Bellón JM, Rodríguez M, Pérez‐Köhler B, Pérez‐López P, Pascual G. The New Zealand White Rabbit as a model for preclinical studies addressing tissue repair at the level of the abdominal wall. Tissue Eng Part C Methods. 2017;23:863–80.

2. Bosze ZS, Houdebine LM. Application of rabbits in biomedical research: a review. World Rabbit Sci. 2006;14:1–14.

3. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol Exp Ther. 1944;82:377–90.

4. Daniel Morton. The Use of Rabbits in Male Reproductive Toxicology. Environmental Health Perspectives. 1988;77:5–9.

5. Duverger N, Kruth H, Emmanuel F, Caillaud JM, Viglietta C, Castro G, et al. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-1 transgenic rabbits. Circulation. 1996;94:713–17.

6. Fisher PG. Standards of care in the 21st century: the rabbit. J Exot Pet Med. 2010;19:22–35.

7. Franco NH. Animal experiments in biomedical research: a historical perspective. Animals. 2013;3:238–73.

8. Harkness JE, Wagner JE. The biology and medicine of rabbits and rodents (2nd Ed.). Lea & Febiger. 1983.

9. Джерело доступу: тhttps://www.toxicology.org/pubs/docs/air/AIR_Final.pdf

10. Hui JH, Chan SW, Li J, et al. Intra‐articular delivery of chondroitin sulfate for the treatment of joint defects in rabbit model. J Mol Histol. 2007;38:483–489.

11. Hunt CE, Harrington DD, Weisbroth SH, Flatt RE, Kraus AL. Nutrition and nutritional diseases of the rabbit. In: The Biology of the Laboratory Rabbit. New York Academic Press: NY;1974,403–33.

12. Джерело доступу: ISO 10993 – 10: 2002.

13. Kondo M, Sakai T, Komeima K, Kurimoto Y, Ueno S, Nishizawa Y, et al. Generation of a transgenic rabbit model of retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2009;50:1371–7. doi: 10.1167/iovs.08-2863

14. Llebenberg SP, Linn JM. Seasonal and sexual influences on rabbit atropinesterase. Lab Anim. 1980;14:297–300.

15. Lv Q, Yuan L, Deng J, Chen M, Wang Y, Zeng J, et al. Efficient generation of myostatin gene mutated rabbit by CRISPR/Cas9. Sci. Rep. 2016;6:25029. doi: 10.1038/srep25029.

16. Oki Y, Doi K, Makihara Y, Kobatake R, Kubo T, Tsuga K. Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model. J Appl Oral Sci. 2017;25:498–505.

17. Pasteur L. Méthode pour prévenir la rage après morsure. C. R. T. 1885;101:765–72.

18. Refinements in rabbit husbandry. SECOND REPORT OF THE BVAAWF/FRAME/RSPCA/UFAW JOINT WORKING GROUP ON REFINEMENT. Laboratory Animals 1993;27:301–29.

19. Sayers I. Approach to preventive health care and welfare in rabbits. In Pract. 2010;32:190–8.

20. Sharpe R. The Draize test-motivations for change. Fd Chem Toxicol 1985;23:139–43.

21. Suckow Mark A, Brammer David W, Rush Howard G, Chrisp Clarence E. "Biology and Diseases of Rabbits." Chapter 9 in Laboratory Animal Medicine, 2nd Edition. James G. Fox, et al, editors. New-York: Academic Press; 2002.

22. Sui T, Xu L, Lau YS, Liu D, Liu T, Gao Y, et al. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations. Cell Death Dis. 2018;9:609.

23. Wang Y, Niimi M, Nishijima K, Waqar AB, Yu Y, Koike T, et al. Human apolipoprotein A-II protects against dietinduced atherosclerosis in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 2013;33:224–31. doi: 10.1161/ATVBAHA.112.300445

24. Weber J, Peng H, Rader C. From rabbit antibody repertoires to rabbit monoclonal antibodies. Exp. Mol. Med. 2017;49:305. doi: 10.1038/emm.2017.23

25. Yanni AE. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim. 2004;38:246–56.


Надійшла до редакції 17/03/2021